Hemorrhagic Stroke, Intracerebral
6
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
16.7%
1 terminated out of 6 trials
66.7%
-19.8% vs benchmark
33%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI
One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy
Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures
Spleen Volume Change Predicts 45-Day Mortality in Neurocritical Care: A Prospective Cohort Study
Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial
CCM Blood Biomarker Validation Study